About
Ciloa bioengineers small extracellular vesicles (sEVs) to develop novel therapeutic and preventive biomedicines for applications including metabolic diseases, oncology, rare diseases, and vaccines against viral threats.
Explore Ciloa's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.